CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF

Bone Marrow Transplantation

Volumn 21, Issue 6, 1998, Pages 561-568

  Cesana, C ^a   Carlo Stella, C ^a   Regazzi, E ^a   Garau, D ^a   Sammarelli, G ^a   Caramatti, C ^a   Tabilio, A ^b   Mangoni, L ^a   Rizzoli, V ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Blood stem cell transplantation; Colony forming cells; Cyclophosphamide; G CSF; LTC IC; PBPC

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; APHERESIS; ARTICLE; AUTOGRAFT; BURST FORMING UNIT E; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMING UNIT GM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LEUKAPHERESIS; LEUKOCYTE CULTURE; LONG TERM CULTURE INITIATING CELL; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL;

EID: 0031933165     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701133     Document Type: Article

References (38)

1. Williams SF, Bitran JD, Richards JM et al. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant 1990; 5: 129-133.
2. Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353-357
3. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human GM-CSF. Blood 1989; 74: 1905-1914.
4. Matsunaga T, Sakamaki S, Kohgo Y et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993; 11: 103-108.
5. + hematopoietic progenitor cells. Blood 1995; 85: 1936-1943.
6. Simmons PJ, Zannettino A, Gronthos S et al. Potential adhesion mechanisms for localisation of haemopoietic progenitors to bone marrow stroma. Leuk Lymphoma 1994; 12: 353-363.
7. Gronthos S, Simmons PJ. The biology and application of human bone marrow stromal cell precursors. J Hematother 1996; 5: 15-23.
8. Civin CI, Gore SD. Antigenic analysis of hematopoiesis: a review. J Hematother 1993; 2: 137-144.
9. Eaves CJ. Peripheral blood stem cells reach new heights. Blood 1993; 82: 1957-1959.
10. Siena S, Bregni M, Brando B et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991; 77: 400-409.
11. + cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp Hematol 1992; 20: 528-530.
12. Brugger W, Bross K, Frisch J et al. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 1992; 79: 1193-1200.
13. + cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens. Bone Marrow Transplant 1994; 13: 479-485.
14. Petzer AL, Hogge DE, Lansdorp PM et al. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 1996; 93: 1470-1474.
15. Udomsakdi C, Lansdorp PM, Hogge DE et al. Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood 1992; 80: 2513-2521.
16. Sutherland HJ, Eaves CJ, Lansdorp PM et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 1994; 83: 3808-3814.
17. Harada M, Nagafuji K, Fujisaki T et al. G-CSF-induced mobilization of peripheral blood stem cells from healthy adults for allogeneic transplantation. J Hematother 1996; 5: 63-71.
18. Scott MA, Gordon MY, In search of the haemopoietic stem cell. Br J Haematol 1995; 90: 738-743.
19. Carlo-Stella C, Mangoni L, Piovani G et al. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood 1994; 83: 1373-1380.
20. Sutherland HJ, Eaves CJ, Eaves AC et al. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro. Blood 1990; 74: 1563-1570.
21. Sutherland HJ, Eaves CJ, Lansdorp PM et al. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 1993; 78: 666-672.
22. Demirer T, Besinger WI. Optimization of peripheral blood stem cell collection. Curr Opin Hematol 1995; 2: 219-226.
23. Pettengell R, Testa NG, Swindell R et al. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood 1993; 82: 2239-2244.
24. + cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplant 1994; 14: 827-832.
25. Drake M, Ranaghan L, Morris TCM et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745-749.
26. Baumann I, Swindell R, Van Hoeff MEHM et al. Mobilisation kinetics of primitive haemopoietic cells following G-CSF with or without chemotherapy for advanced breast cancer. Ann Oncol 1996; 7: 1051-1057.
27. Shirota T, Tavassoli M, Cyclophosphamide-induced alterations of bone marrow endothelium: implications in homing of marrow cells after transplantation. Exp Hematol 1991; 19: 369-373.
28. Scott MA, Apperley JF, Bloxham DM et al. Biological properties of peripheral blood progenitor cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor. Br J Haematol 1997; 97: 474-480.
29. Prosper F, Stroncek D, Van Overbeke K et al. Primitive LTC-IC in G-CSF mobilized PBPC have similar in vitro expansion potential as LTC-IC in steady state marrow. Blood 1996; 88 (Suppl. 1): 457a (Abstr.).
30. Besinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologie malignancies: a retrospective comparison with marrow transplantation. Blood 1996; 88: 2794-2800.
31. Besinger W, Singer J, Appelbaum F et al. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 1993; 81: 3158-3163.
32. Neben S, Marcus K, Mauch P. Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood 1993; 81: 1960-1967.
33. Gordon MY, Greaves MF. Physiological mechanisms of stem cell regulation in bone marrow transplantation and haemopoiesis. Bone Marrow Transplant 1989; 4: 335-338.
34. Lemieux ME, Rebel VI, Landsorp PM et al. Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow 'switch' cultures. Blood 1995; 86: 1339-1347.
35. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behaviour of hematopoietic stem cells. Cell 1986; 45: 917-927.
36. Jordan CT, Lemischka IR. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Devel 1990; 4: 220-232.
37. Gordon MY, Blackett NM, Lewis JL et al. Evidence for a mechanism that can provide both short-term and long-term haemopoietic repopulation by a seemingly uniform population of primitive human haemopoietic precursor cells. Leukemia 1995; 9: 1252-1256.
38. Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1977; 20: 465-471.